Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
564.60
+7.39 (1.33%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Thermo Fisher Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1995
Cash & Equivalents
8,0778,5244,47710,3252,399
Upgrade
Short-Term Investments
30000
Upgrade
Cash & Cash Equivalents
8,0808,5244,47710,3252,399
Upgrade
Cash Growth
-5.21%90.40%-56.64%330.39%14.08%
Upgrade
Receivables
8,2218,1157,9775,7414,349
Upgrade
Inventory
5,0885,6345,0514,0293,370
Upgrade
Other Current Assets
3,2002,9562,6081,8621,775
Upgrade
Total Current Assets
24,58925,22920,11321,95711,893
Upgrade
Property, Plant & Equipment
9,4489,2808,3335,9124,749
Upgrade
Goodwill and Intangibles
60,69058,63862,03738,72639,728
Upgrade
Other Long-Term Assets
3,9994,0074,6402,4572,011
Upgrade
Total Long-Term Assets
74,13771,92575,01047,09546,488
Upgrade
Total Assets
98,72697,15495,12369,05258,381
Upgrade
Accounts Payable
2,8723,3812,8672,1751,920
Upgrade
Deferred Revenue
2,6892,6012,6551,271916
Upgrade
Current Debt
3,6095,5792,5372,628676
Upgrade
Other Current Liabilities
4,8425,4495,3774,2302,685
Upgrade
Total Current Liabilities
14,01217,01013,43610,3046,197
Upgrade
Long-Term Debt
31,30828,90932,33319,10717,076
Upgrade
Other Long-Term Liabilities
6,6827,2038,4995,1245,433
Upgrade
Total Long-Term Liabilities
37,99036,11240,83224,23122,509
Upgrade
Total Liabilities
52,00253,12254,26834,53528,706
Upgrade
Total Debt
34,91734,48834,87021,73517,752
Upgrade
Debt Growth
1.24%-1.10%60.43%22.44%-6.52%
Upgrade
Retained Earnings
47,36441,91035,43128,11622,092
Upgrade
Comprehensive Income
-3,224-3,099-2,329-2,807-2,679
Upgrade
Shareholders' Equity
46,73543,97840,79334,50729,675
Upgrade
Net Cash / Debt
-26,837-25,964-30,393-11,410-15,353
Upgrade
Net Cash Per Share
-69.17-65.90-76.56-28.60-38.10
Upgrade
Working Capital
10,5778,2196,67711,6535,696
Upgrade
Book Value Per Share
121.08112.19103.5487.1474.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).